Inhaled therapy in cystic fibrosis: agents, devices and regimens

被引：51
作者：
Agent, Penny [1 ]
Parrott, Helen [1 ]
机构：
[1] Royal Brompton & Harefield NHS Fdn Trust, London, England
来源：
BREATHE | 2015年 / 11卷 / 02期
关键词：
D O I：
10.1183/20734735.021014
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
The recognised mainstay daily treatments for cystic fibrosis (CF) focus on inhaled and oral medications, airway clearance and optimised nutrition. This review discusses recent advances in inhaled therapies for the management of CF, including devices such as intelligent nebulisers, drug formulations and supporting evidence for inhaled antibiotics (for the management of chronic Pseudomonas aeruginosa) and muco-active drugs. We include practical advice for clinicians regarding the optimisation of inhalation technique and education. The influence of adherence on the use of inhaled therapies in CF is also reviewed.
引用
收藏
页码：111 / 118
页数：8
相关论文
共 49 条
  • [1] Long-Term Inhaled Dry Powder Mannitol in Cystic Fibrosis An International Randomized Study
    Aitken, Moira L.
    Bellon, Gabriel
    De Boeck, Kris
    Flume, Patrick A.
    Fox, Howard G.
    Geller, David E.
    Haarman, Eric G.
    Hebestreit, Helge U.
    Lapey, Allen
    Schou, I. Manjula
    Zuckerman, Jonathan B.
    Charlton, Brett
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (06) : 645 - 652
  • [2] Adherence to nebulised therapies in adolescents with cystic fibrosis is best on week-days during school term-time
    Ball, Rosemary
    Southern, Kevin W.
    McCormack, Pamela
    Duff, Alistair J. A.
    Brownlee, Keith G.
    McNamara, Paul S.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2013, 12 (05) : 440 - 444
  • [3] Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study
    Bilton, D.
    Robinson, P.
    Cooper, P.
    Gallagher, C. G.
    Kolbe, J.
    Fox, H.
    Jaques, A.
    Charlton, B.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (05) : 1071 - 1080
  • [4] Bilton D, 2014, J CYST FIBROS, V13, pS65
  • [5] Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosis
    Bilton, Diana
    Bellon, Gabriel
    Charlton, Brett
    Cooper, Peter
    De Boeck, Kris
    Flume, Patrick A.
    Fox, Howard G.
    Gallagher, Charles G.
    Geller, David E.
    Haarman, Eric G.
    Hebestreit, Helge U.
    Kolbe, John
    Lapey, Allen
    Robinson, Phil
    Wu, Jian
    Zuckerman, Jonathan B.
    Aitken, Moira L.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2013, 12 (04) : 367 - 376
  • [6] Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection
    Clancy, J. P.
    Dupont, L.
    Konstan, M. W.
    Billings, J.
    Fustik, S.
    Goss, C. H.
    Lymp, J.
    Minic, P.
    Quittner, A. L.
    Rubenstein, R. C.
    Young, K. R.
    Saiman, L.
    Burns, J. L.
    Govan, J. R. W.
    Ramsey, B.
    Gupta, R.
    [J]. THORAX, 2013, 68 (09) : 818 - 825
  • [7] Conway SP, 2002, J CYSTIC FIBROSIS S1, V1, pS67
  • [8] Cystic fibrosis trust, 2011, STAND CLIN CAR CHILD
  • [9] Cystic Fibrosis Trust, 2011, STAND CAR GOOD CLIN
  • [10] Accurate Assessment of Adherence Self-Report and Clinician Report vs Electronic Monitoring of Nebulizers
    Daniels, Tracey
    Goodacre, Lynne
    Sutton, Chris
    Pollard, Kim
    Conway, Steven
    Peckham, Daniel
    [J]. CHEST, 2011, 140 (02) : 425 - 432
12345